Evaluation of the Safety and Effectiveness of BELKYRA® Inj. for the Treatment of Patients With Submental Fullness Due to Submental Fat: A Postmarketing Surveillance Study in Korea
Study Identifier
CMO-EPI-FAS-0537
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Details
Medical Condition
Study Drug
Phase
N/A
Sex
Female & Male
Age
18+ years
Protocol Summary
The purpose of this PMS study is to evaluate the safety and effectiveness of BELKYRA Inj. used according to the dose specified in the instructions for use, for the treatment of patients with SM fullness due to SMF, through active investigation under routine clinical practice
Study Locations
Location
Status
Location
Oracle-Dermatology
Daejeon, Republic of Korea, 35234
Status
Not applicable
Location
Goldenview plastic surgery
Seoul, Republic of Korea, 06010
Status
Not applicable
Location
(Apgujeong) Oracle-Dermatology
Seoul, Republic of Korea, 06022
Status
Not applicable
Location
Dream-Dermatology
Seoul, Republic of Korea, 06030
Status
Not applicable